Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

Blood Cancer
Cancer
CAR-T
Cancer Treatment
Prostate Cancer
Breast Cancer
Lung Cancer
Topics

Advertisement

Advertisement

Blood Cancer

Share

Top Latest Popular

In the last 4 hours

Mum thought hot flushes were normal before cancer diagnosis Sheffield Star 09:26

Friday

Blood Cancer Drug Denials; Body Fat and Pancreas Cancer; Studies With Fake Citations Medpage Today 19:26 Fri, 23 Oct

Age Gap in Mantle Cell Lymphoma Survival Narrows With Newer Therapies Rare Disease Advisor 18:44 Fri, 23 Oct

Advertisement

Advertisement

Thursday

CAR T-Cell Therapy Delivers Durable Responses in R/R MCL, Other Lymphomas Rare Disease Advisor 21:58 Thu, 22 Oct

Wednesday

A Deep Dive Into Double-Hit Lymphoma Medpage Today 14:51 Wed, 21 Oct

Tuesday

Adverse Family Outcomes Reported for Children With B-Cell ALL Psychiatry Advisor 16:11 Tue, 20 Oct

CHMP backs TALVEY plus daratumumab for earlier myeloma use PharmaTimes 14:31 Tue, 20 Oct

Boryung's lymphoma drug bosmolisib advances toward 2028 trial completion Korea Biomedical Review 05:44 Tue, 20 Oct

Monday

Efficacy and safety of ifupinostat in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm phase 2 study Nature.com 00:17 Mon, 19 Oct

Advertisement

In the last month

Aberrant Marker Expression Complicates Mantle Cell Lymphoma Diagnosis Rare Disease Advisor 23:04 Fri, 16 Oct

Mantle Cell Lymphoma Markers Identify More Aggressive Disease Rare Disease Advisor 21:22 Fri, 16 Oct

J&J Says Chmp Recommends Approval Of Talvey Combo In Earlier Line Treatment Of R/R Multiple Myeloma RTT News 13:21 Fri, 16 Oct

Blood Cancer United awards grant to diversify clinical trial access News-Medical.Net 19:11 Thu, 15 Oct

Systemic Mastocytosis With Myeloid Neoplasm Tied to Poorer Survival Rare Disease Advisor 18:18 Thu, 15 Oct

Legend Biotech Wins FDA Clearance For In Vivo car-T Therapy LB2501; Stock Up RTT News 15:37 Thu, 15 Oct

The Wildhearts frontman Ginger Wildheart, 61, marries partner Jane Graley seven months after being diagnosed with terminal cancer MailOnline 12:03 Thu, 15 Oct

Bispecific antibodies, CAR-T therapy improve outcomes in follicular lymphoma: expert Korea Biomedical Review 08:45 Thu, 15 Oct

Calls for better post-cancer care to give isolated survivors support ABC Online 21:26 Wed, 14 Oct

Reprogrammed NK immune cells target cancer and autoimmune disorders ecancer 16:59 Wed, 14 Oct

Even highly curable childhood cancers take a substantial toll on families ecancer 14:17 Wed, 14 Oct

Blinatumomab Significantly Improves EFS in High-Risk Pediatric ALL Rare Disease Advisor 19:15 Tue, 13 Oct

Childhood leukemia treatment causes rapid, lasting challenges for patient families News-Medical.Net 19:13 Tue, 13 Oct

Even Highly Curable Childhood Cancers Take a Substantial Toll on Families, According to New Study from JNCCN Newswise (Press Release) 14:06 Tue, 13 Oct

Teen 'detached from reality' to cope with return of aggressive cancer BBC 22:08 Sun, 11 Oct

A deep hybrid feature extraction model based on MobileNet and vision transformer for acute lymphoblastic leukemia prediction Nature.com 01:41 Sun, 11 Oct

Caribou Biosciences Halts Off-the-Shelf CRISPR CAR-T Programs for Lymphoma and Myeloma After Failing to Fund Phase 3 Trial Medical Daily 20:18 Sat, 10 Oct

Targeting FcRL5 in multiple myeloma: biological rationale and strategic sequencing beyond Bcma and GPRC5D Nature.com 16:17 Fri, 09 Oct

Epcoritamab Plus R-CHOP Improves PFS in Frontline DLBCL Oncology Nurse Advisor 15:58 Fri, 09 Oct

Ibrutinib Plus Venetoclax Shows High Complete Response Rate in First-Line MCL Hematology Advisor 15:01 Fri, 09 Oct

BMS’s Zenbexus meets PFS endpoint in pivotal multiple myeloma trial Clinical Trials Arena 09:01 Fri, 09 Oct

Subcutaneous isatuximab by on-body-injector plus bortezomib, lenalidomide, and dexamethasone in newly diagnosed transplant-ineligible multiple myeloma: Isasocut study Nature.com 03:54 Fri, 09 Oct

Dunedin Cancer Patient Urges People To Sign Parliamentary Petition To Restore Public Dermatology Services Scoop 01:10 Fri, 09 Oct

Adding Epcoritamab to R-CHOP Cut Lymphoma Progression or Death Risk by 51% in Topline Phase 3 Trial Results Medical Daily 23:10 Thu, 08 Oct

Rituximab Maintenance Improves Survival After Bendamustine-Rituximab in MCL Rare Disease Advisor 21:03 Thu, 08 Oct

Two-Year EVS Predicts Near-Normal Survival in Contemporary MCL Rare Disease Advisor 20:12 Thu, 08 Oct

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma Pharmafile 16:30 Thu, 08 Oct

Holywood woman urges vigilance after lymphoma battle News Letter 14:09 Thu, 08 Oct

Ashley Park on Surviving Blood Cancer Prevention.com 19:47 Wed, 07 Oct

Insurance Denials, Costs Hamper Access to Specialty Oral Blood Cancer Medications Oncology Nurse Advisor 17:05 Wed, 07 Oct

Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down STAT 09:41 Wed, 07 Oct

Advertisement

My Local News

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
- Cancer Cancer
  Back to Health Cancer
  - Blood Cancer
  - Breast Cancer
  - Cancer Research
  - Cancer Treatment
  - CAR-T CAR-T
  - Cervical Cancer
  - Cervical Screening
  - Colorectal Cancer
  - HPV HPV
  - Leukaemia Leukaemia
  - Lung Cancer
  - Ovarian Cancer
  - Prostate Cancer